Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Hopewell › NPI 1285671248
Hospital

Columbia/Hca John Randolph, INC.

Columbia/Hca John Randolph, INC. was paid $49.09M by Medicaid between Jan 2018 and Dec 2024, across 221 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.

33Billing provider infoCOLUMBIA/HCA JOHN RANDOLPH, INC.
HOPEWELL, VA 23860
33aNPI1285671248assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$49.09M
24GClaims1,142,966
24DCodes billed221
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Virginia

Rank by total paid#15 of 80
Median peer was paid$14.69M
This provider vs. median3.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018112,402$3.26M
2019164,304$5.68M
2020153,602$6.63M
2021175,409$7.43M
2022171,585$7.93M
2023193,773$9.45M
2024incomplete171,891$8.70M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 42% 122,527 103,935 $20.53M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 49,087 41,555 $7.90M
99282 Emergency department visit for the evaluation and management, low to moderate severity 8.0% 23,880 21,423 $3.94M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.0% 10,605 9,486 $1.94M
70450 Computed tomography, head or brain; without contrast material 3.8% 10,451 9,203 $1.87M
96361 Intravenous infusion, hydration; each additional hour 3.6% 6,677 5,883 $1.79M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.1% 9,453 8,290 $1.51M
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.0% 5,792 5,433 $1000K
71275 Computed tomographic angiography, chest, with contrast material 2.0% 4,333 3,884 $977K
G0378 Hospital observation service, per hour 1.6% 6,273 3,327 $774K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.5% 1,487 1,343 $742K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.4% 3,982 3,449 $671K
209 more codes
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 18,592 $431K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 9,984 $339K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,690 $296K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,391 $242K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 681 $224K
10060 <1% 1,519 $210K
12001 <1% 759 $167K
93971 <1% 1,753 $147K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 281 $141K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,655 $132K
G0410 Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes <1% 1,403 $117K
G0177 Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) <1% 1,540 $115K
80053 Comprehensive metabolic panel <1% 36,666 $109K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,200 $107K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 969 $104K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,438 $103K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,385 $102K
72125 Computed tomography, cervical spine; without contrast material <1% 3,339 $101K
97163 <1% 926 $99K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 494 $94K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 148 $90K
80048 Basic metabolic panel (calcium, ionized) <1% 22,335 $88K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 141 $77K
71046 Radiologic examination, chest; 2 views <1% 18,398 $74K
12011 <1% 319 $69K
90853 Group psychotherapy (other than of a multiple-family group) <1% 684 $68K
76801 <1% 1,826 $66K
76830 Ultrasound, transvaginal <1% 1,007 $66K
70491 <1% 292 $59K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 31,355 $58K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 8,523 $57K
83880 <1% 8,277 $55K
71250 <1% 945 $53K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 693 $53K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,260 $53K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 731 $50K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 25,879 $45K
71045 Radiologic examination, chest; single view <1% 21,697 $44K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,814 $42K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 14,922 $37K
12002 <1% 155 $35K
72131 <1% 681 $33K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 131 $31K
85027 <1% 59,454 $31K
74174 <1% 133 $30K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 29 $28K
84484 <1% 22,690 $27K
87040 <1% 4,438 $26K
90715 <1% 1,646 $26K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,494 $25K
76642 <1% 223 $25K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 921 $24K
70486 <1% 659 $24K
85379 <1% 6,057 $23K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,166 $23K
96375 Therapeutic injection; each additional sequential IV push <1% 16,175 $22K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 581 $18K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 242 $18K
73030 <1% 3,254 $18K
93970 <1% 121 $15K
80076 <1% 7,471 $15K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 24,084 $14K
29125 <1% 104 $14K
72110 <1% 1,183 $13K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 41 $12K
74018 <1% 1,930 $12K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 52 $10K
81001 <1% 32,706 $9K
73564 <1% 2,727 $9K
73502 <1% 1,458 $8K
73610 <1% 3,796 $8K
97116 <1% 362 $8K
J7030 Infusion, normal saline solution , 1000 cc <1% 21,059 $8K
J7120 Ringers lactate infusion, up to 1000 cc <1% 8,496 $8K
73130 <1% 3,351 $8K
73630 <1% 4,060 $8K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 497 $7K
80051 <1% 2,780 $6K
90791 Psychiatric diagnostic evaluation <1% 36 $6K
83605 <1% 4,900 $6K
84443 Thyroid stimulating hormone (TSH) <1% 3,112 $6K
82565 <1% 3,846 $6K
72100 <1% 1,129 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 1,879 $5K
73562 <1% 1,594 $5K
81025 <1% 25,054 $5K
73110 <1% 2,254 $5K
96368 <1% 128 $5K
83690 <1% 18,987 $5K
83735 <1% 20,194 $5K
70498 <1% 41 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 7,661 $4K
97166 <1% 55 $4K
84702 <1% 5,034 $4K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,860 $4K
80061 Lipid panel <1% 1,305 $3K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 31,825 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 14,420 $3K
81003 <1% 16,015 $3K
73080 <1% 1,027 $3K
85610 <1% 8,007 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,199 $3K
36415 Collection of venous blood by venipuncture <1% 1,559 $3K
76870 <1% 33 $3K
84703 <1% 6,454 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,352 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 8,409 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 4,537 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 24,769 $2K
72141 <1% 14 $2K
96376 <1% 2,851 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,014 $2K
87070 <1% 12,643 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 16,646 $2K
73590 <1% 819 $2K
73140 <1% 976 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 22,938 $1K
82553 <1% 359 $1K
70551 Magnetic resonance imaging, brain; without contrast material <1% 13 $1K
73700 <1% 14 $1K
G0176 Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more) <1% 77 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 6,481 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,981 $1K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 5,514 $1K
72128 <1% 41 $1K
87210 <1% 8,169 $1K
85730 <1% 5,155 $1K
74022 <1% 206 $965.09
82550 <1% 2,418 $959.11
82947 <1% 2,778 $926.59
86850 <1% 1,353 $914.00
97535 Self-care/home management training, each 15 minutes <1% 76 $881.15
84520 <1% 2,941 $823.31
73090 <1% 512 $696.35
86900 <1% 1,971 $670.46
94644 <1% 88 $666.45
74019 <1% 119 $578.38
77065 Tomosynthesis, mammo <1% 26 $552.20
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 75 $539.17
77066 Tomosynthesis, mammo <1% 26 $507.17
88304 <1% 625 $506.90
84100 <1% 1,442 $496.41
J2270 Injection, morphine sulfate, up to 10 mg <1% 7,016 $477.11
72050 <1% 12 $456.28
71101 <1% 142 $408.51
J0561 Injection, penicillin g benzathine, 100,000 units <1% 40 $394.06
J1170 Injection, hydromorphone, up to 4 mg <1% 4,865 $378.70
86901 <1% 1,971 $378.40
72040 <1% 101 $371.90
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,458 $371.80
87807 <1% 5,584 $309.21
73552 <1% 67 $295.06
87077 <1% 1,695 $290.24
87186 <1% 2,839 $280.99
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,804 $248.52
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 53 $226.52
87205 <1% 1,126 $223.86
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,452 $218.76
73560 <1% 43 $182.81
J1644 Injection, heparin sodium, per 1000 units <1% 2,186 $182.30
76000 <1% 62 $180.94
86140 <1% 163 $176.13
J2060 Injection, lorazepam, 2 mg <1% 1,698 $140.46
J0780 Injection, prochlorperazine, up to 10 mg <1% 717 $137.18
J1815 Injection, insulin, per 5 units <1% 2,106 $129.79
82248 <1% 573 $129.41
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,733 $123.76
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,846 $109.83
84439 <1% 44 $97.57
80069 <1% 21 $84.75
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,186 $75.20
82010 <1% 373 $71.22
73060 <1% 13 $64.25
J7050 Infusion, normal saline solution, 250 cc <1% 4,806 $60.55
J1630 Injection, haloperidol, up to 5 mg <1% 485 $44.89
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,071 $44.72
J2704 Injection, propofol, 10 mg <1% 1,523 $35.55
87088 <1% 438 $23.67
84132 <1% 88 $21.68
J7510 Prednisolone oral, per 5 mg <1% 1,029 $20.94
J0690 Injection, cefazolin sodium, 500 mg <1% 629 $19.49
87147 <1% 358 $18.73
82272 <1% 103 $17.99
86308 <1% 102 $14.52
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 2,540 $14.30
J3480 Injection, potassium chloride, per 2 meq <1% 138 $12.70
J3370 Injection, vancomycin hcl, 500 mg <1% 150 $6.91
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 576 $6.87
J0360 Injection, hydralazine hcl, up to 20 mg <1% 15 $2.74
C9113 Injection, pantoprazole sodium, per vial <1% 17 $1.38
85018 <1% 14 $0.48
85014 <1% 14 $0.48
J3535 Drug administered through a metered dose inhaler 0% 313 $0.00
J3490 Unclassified drugs 0% 2,315 $0.00
A9270 Non-covered item or service 0% 5,300 $0.00
A9698 Non-radioactive contrast imaging material, not otherwise classified, per study 0% 129 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 101 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 413 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 168 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 28 $0.00
73660 0% 13 $0.00
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 0% 224 $0.00
S0028 Injection, famotidine, 20 mg 0% 519 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 245 $0.00
72070 0% 31 $0.00
88312 0% 17 $0.00
J0736 Injection, clindamycin phosphate, 300 mg 0% 13 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 134 $0.00
C1776 Joint device (implantable) 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMAREK, PATRICK (CFO)
Same official

Other billing entities under MAREK, PATRICK

Full network →
ProviderLocationPaid
Columbia/Hca John Randolph, INC.Prince George, VA$264K
Columbia/Hca John Randolph, INC.Hopewell, VA$88K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.